Skip to main content
Log in

Surveillance for gestational trophoblastic neoplasia after molar pregnancy not cost effective in the US

  • Non-clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Albright BB, et al. Surveillance for gestational trophoblastic neoplasia following molar pregnancy: A cost-effectiveness analysis. American Journal of Obstetrics and Gynecology : 29 May 2021. Available from: URL: http://doi.org/10.1016/j.ajog.2021.05.031

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Surveillance for gestational trophoblastic neoplasia after molar pregnancy not cost effective in the US. PharmacoEcon Outcomes News 880, 29 (2021). https://doi.org/10.1007/s40274-021-7787-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7787-8

Navigation